Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,887 | 93,088 | 66,460 | 72,034 | 101,815 |
| Marketable Securities | 156,666 | 149,877 | 200,290 | 260,623 | 200,142 |
| Receivables | 397 | 40,221 | 249 | 637 | 668 |
| Inventories | 5,340 | 1,586 | N/A | N/A | N/A |
| Other current assets | 0 | 10,308 | 0 | 0 | 190 |
| TOTAL | $224,182 | $295,080 | $283,046 | $346,984 | $314,389 |
| Non-Current Assets | |||||
| PPE Net | 5,852 | 6,300 | 7,270 | 8,328 | 9,109 |
| Other Non-Current Assets | 72,049 | 75,040 | 78,000 | 80,809 | 73,782 |
| TOTAL | $77,901 | $81,340 | $85,270 | $89,137 | $82,891 |
| Total Assets | $302,083 | $376,420 | $368,316 | $436,121 | $397,280 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,068 | 6,871 | 11,296 | 12,799 | 11,945 |
| Accrued Expenses | 8,913 | 17,659 | 17,605 | 16,317 | 16,381 |
| Other current liabilities | 20,205 | 21,394 | 22,813 | 19,776 | 8,303 |
| TOTAL | $67,876 | $78,916 | $72,244 | $65,688 | $101,562 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,924 | 8,000 | 2,662 | 1,671 | 50,943 |
| Other Non-Current Liabilities | 91,206 | 93,864 | 66,621 | 69,625 | 26,402 |
| TOTAL | $169,247 | $170,864 | $108,959 | $112,954 | $71,402 |
| Total Liabilities | $237,123 | $249,780 | $181,203 | $178,642 | $172,964 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,919 | 3,837 | 3,795 | 3,774 | 3,736 |
| Common Shares | 10 | 10 | 9 | 9 | 9 |
| Retained earnings | -1,767,795 | -1,693,024 | -1,618,452 | -1,534,361 | -1,552,827 |
| Other shareholders' equity | -1,237 | -2,067 | -2,959 | -2,618 | -1,892 |
| TOTAL | $64,960 | $126,640 | $187,113 | $257,479 | $224,316 |
| Total Liabilities And Equity | $302,083 | $376,420 | $368,316 | $436,121 | $397,280 |